Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal photoreceptor cell-surface receptors comprise a diverse group of membrane-bound proteins located on the outer segments of rod and cone cells, serving as the primary interface for light detection in the visual system (NIH, 2019). The most prominent members are the opsins, such as rhodopsin in rods and various photopsins in cones, which are G protein-coupled receptors (GPCRs) that initiate the phototransduction cascade upon photon absorption (Science, 2007; ARVO, 2018). This category also encompasses ion channels, such as cyclic nucleotide-gated (CNG) channels, and various signaling receptors like STRA6 and dopamine receptors that regulate photoreceptor health, synaptic transmission, and the visual cycle (NIH, 2024). Mutations in these receptors or their associated signaling components are the underlying cause of numerous inherited retinal dystrophies, including retinitis pigmentosa and Leber congenital amaurosis, which lead to progressive photoreceptor cell death and blindness (OUP, 2024). Therapeutic strategies targeting these receptors include the development of pharmacological chaperones to stabilize mutant proteins, visual cycle modulators to reduce toxic byproduct accumulation, and optogenetic therapies that introduce exogenous light-sensitive receptors into the retina to restore vision (NIH, 2024; Nanoscope Therapeutics, 2024).
Modulation of the phototransduction cascade, visual cycle inhibition, GPCR signaling antagonism/agonism, and optogenetic restoration of light sensitivity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal photoreceptor cell-surface receptors.